Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in adults 50 to 65 years of age in India: An open-label trial

Streptococcus pneumoniae infection is a major global public health concern in older adults, especially as life expectancy continues to increase in most countries, including India. Recently, a 13-valent pneumococcal conjugate vaccine (PCV13) with the ability to enhance immunity (immunologic memory) o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Solanki, Bhagirath B., Juergens, Christine, Chopada, Manojkumar B., Supe, Pravin, Sundaraiyer, Vani, Le Dren-Narayanin, Natacha, Cutler, Mark W., Gruber, William C., Scott, Daniel A., Schmoele-Thoma, Beate
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5612423/
https://ncbi.nlm.nih.gov/pubmed/28881165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1331796
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados